SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-008039
Filing Date
2022-03-01
Accepted
2022-03-01 16:13:09
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20220301.htm   iXBRL 8-K 38240
2 EX-99.1 xene-ex991_6.htm EX-99.1 161787
3 GRAPHIC g4y5ew2oix1b000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-22-008039.txt   352085

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xene-20220301.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20220301_lab.xml EX-101.LAB 19290
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20220301_pre.xml EX-101.PRE 11483
8 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20220301_htm.xml XML 3530
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 22698132
SIC: 2834 Pharmaceutical Preparations